<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2257">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01081743</url>
  </required_header>
  <id_info>
    <org_study_id>RCB : 2009-A00326-51</org_study_id>
    <nct_id>NCT01081743</nct_id>
  </id_info>
  <brief_title>Effectiveness of Care Management in Alzheimer Patients</brief_title>
  <acronym>AIDALZ</acronym>
  <official_title>Evaluation de la Mise en Place d'un Auxiliaire d'évaluation Dans la Prise en Charge de la Maladie d'Alzheimer et Des Maladies apparentées en France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Sante Publique, d'Epidemiologie et de Developpement</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Sante Publique, d'Epidemiologie et de Developpement</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Context: The French Alzheimer plan 2008-2012 includes the implementation of &quot;disease&#xD;
      managers&quot; or social workers, from the onset of the disease, for every patient with a&#xD;
      diagnosis of Alzheimer disease or associated disorder. However, previous trials evaluating&#xD;
      the efficacy of a systematic intervention for each case from the onset of the disease,&#xD;
      including non complex cases, have shown little evidence.&#xD;
&#xD;
      Objective: To evaluate the efficacy of a social worker to prevent behavioural problem for&#xD;
      patient with a new diagnosis of Alzheimer disease or associated disorder.&#xD;
&#xD;
      Design and setting: Multicentric cluster randomized control trial. Patients from several&#xD;
      memory consultations and specialists (neurologist, psychiatrist or geriatrician) in France&#xD;
      are included.&#xD;
&#xD;
      Intervention: In addition to usual care, patients in the intervention group have systematic&#xD;
      home visits from a social worker and regular follow-ups by phone over a one-year period. This&#xD;
      social worker informs the patient and caregiver, evaluates the needs, gives advices to&#xD;
      prevent complications and is a link between the patient and the memory consultation or the&#xD;
      specialist. Patient in the control group have absolutely no intervention and are followed-up&#xD;
      as usually. In order to not modify the usual care, they have no information on their&#xD;
      participation in this trial before the one-year evaluation.&#xD;
&#xD;
      Main outcome measure: NeuroPsychiatric Inventory (NPI) administrated at one year, which&#xD;
      evaluates frequency, severity and repercussion of several behavioural problems. Secondary&#xD;
      outcomes included disability, cognition, depression, health, quality of life,&#xD;
      institutionalization, and resource use.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 24, 2009</start_date>
  <completion_date type="Actual">October 2, 2013</completion_date>
  <primary_completion_date type="Actual">October 2, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NeuroPsychiatric Inventory (NPI)</measure>
    <time_frame>1 year</time_frame>
    <description>Evaluation of frequency, severity and repercussion of several behavioural problems</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cohen-Mansfield Agitation Inventory (CMAI)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apathy Inventory</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disablement Assessment for Dementia (DAD)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini Mental State Examination (MMSE)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Deterioration Scale (GDS)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Montgomery-Asberg Depression Rating Scale (MADRS)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire Quality of Life - Alzheimer's Disease (QoL-AD)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden Interview of Zarit</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization in dementia scale (RUD Lite)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical Outcome Study Short Form 36-item health survey (MOS SF-36)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Institutionalization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tiredness scale</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">270</enrollment>
  <condition>Alzheimer Disease or Associated Disorder</condition>
  <condition>Mild to Moderately Severe Dementia</condition>
  <arm_group>
    <arm_group_label>Social worker</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group is followed-up as usually (usual care)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intervention of the social worker</intervention_name>
    <description>Systematic home visits and regular follow-ups by phone from a social worker</description>
    <arm_group_label>Social worker</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of Alzheimer's Disease or other dementia (Diagnostic and&#xD;
             Statistical Manual of Mental Disorders, Fourth Edition [DSM IV] criteria of dementia)&#xD;
&#xD;
          -  Presence of an informal caregiver&#xD;
&#xD;
          -  Mild to moderately severe dementia (MMSE [10-28])&#xD;
&#xD;
          -  Diagnosis of dementia made by a specialist ≤ 6 months&#xD;
&#xD;
          -  Patient affiliated to the national health insurance system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Institutionalized patient&#xD;
&#xD;
          -  Patient on legal guardianship&#xD;
&#xD;
          -  Behavioural problem with important clinical repercussion&#xD;
&#xD;
          -  Psychotic syndrome&#xD;
&#xD;
          -  Severe and unstable general pathology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ISPED (Institut de Santé Publique, d'Epidémiologie et de Développement)</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>March 4, 2010</study_first_submitted>
  <study_first_submitted_qc>March 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2010</study_first_posted>
  <last_update_submitted>August 25, 2017</last_update_submitted>
  <last_update_submitted_qc>August 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer</keyword>
  <keyword>Dementia</keyword>
  <keyword>Mild to moderately severe</keyword>
  <keyword>New diagnosis</keyword>
  <keyword>Prevention of behavioural problems</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

